Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

1,123 companies

Ticker	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS ▾
RNTX	Rein Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$49.87M	n/a	-294.8%	n/a	-$1.96
SLAB	Silicon Laboratories Inc. Manufacturing · Year ended 2026-01-03 · USD	$784.76M	-$64.91M	-8.3%	-5.9%	34.3%	-$1.98
SLDB	Solid Biosciences Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$174.32M	n/a	-96.8%	n/a	-$1.99
MTNB	Matinas BioPharma Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$10.35M	n/a	-214.2%	n/a	-$2.00
RCKT	Rocket Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$223.12M	n/a	-80.5%	n/a	-$2.01
TYRA	Tyra Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$119.95M	n/a	-46.3%	n/a	-$2.01
SILC	Silicom Ltd. Manufacturing · Year ended 2025-12-31 · USD	$61.93M	-$11.48M	-18.5%	-9.8%	6.6%	-$2.01
ACRV	Acrivon Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$77.91M	n/a	-69.2%	n/a	-$2.02
KANP	Kaanapali Land LLC Finance & Real Estate · Year ended 2025-12-31 · USD	$1.65M	-$3.73M	-226.5%	-4.8%	-15.7%	-$2.02
VYGR	Voyager Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$40.37M	-$119.72M	-296.5%	-61.1%	-49.5%	-$2.04
PTGX	Protagonist Therapeutics, Inc Manufacturing · Year ended 2025-12-31 · USD	$46.02M	-$130.15M	-282.8%	-21.2%	-89.4%	-$2.05
DFTX	Definium Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$183.79M	n/a	-55.3%	n/a	-$2.06
LITS	Lite Strategy, Inc. Manufacturing · Year ended 2026-06-30 · USD	n/a	-$71.15M	n/a	-170.9%	n/a	-$2.06
CGON	CG Oncology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$4.04M	-$161.00M	n/m	-21.4%	254.7%	-$2.08
CABA	Cabaletta Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$167.86M	n/a	-149.8%	n/a	-$2.10
CARL	Carlsmed, Inc. Manufacturing · Year ended 2025-12-31 · USD	$50.51M	-$29.63M	-58.7%	-30.0%	85.9%	-$2.12
PEPG	PepGen Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$89.66M	n/a	-60.8%	n/a	-$2.12
AVX	Avax One Technology Ltd. Finance & Real Estate · Year ended 2025-12-31 · USD	$2.34M	-$33.20M	n/m	-17.8%	n/m	-$2.15
COGT	Cogent Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$328.94M	n/a	-51.7%	n/a	-$2.16
CTNM	Contineum Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$59.98M	n/a	-23.0%	n/a	-$2.17
MGRX	Mangoceuticals, Inc. Services · Year ended 2025-12-31 · USD	$456.0K	-$20.64M	n/m	-135.8%	-26.0%	-$2.17
SMR	Nuscale Power Corp Manufacturing · Year ended 2025-12-31 · USD	$31.48M	-$355.79M	n/m	-30.4%	-15.0%	-$2.17
ANRO	Alto Neuroscience, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$63.24M	n/a	-41.8%	n/a	-$2.19
SLGL	Sol-Gel Technologies Ltd. Manufacturing · Year ended 2025-12-31 · USD	$19.39M	-$6.13M	-31.6%	-26.9%	68.0%	-$2.19
TCRT	Alaunos Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$5.0K	-$4.18M	n/m	-194.0%	-50.0%	-$2.20

Rows per page: 2550 100